Morris Innovative is a biotechnology and health care startup specializing in cardiovascular device manufacturing and sales. The company's flagship FDA-approved closure device, known as the Femoral Introducer Sheath and Hemostasis Device (FISH™), features a novel approach to vascular closure using a ribbon of extracellular matrix called small intestinal submucosa (SIS®).
FISH™ stands out as the first device to combine vessel access and closure into one, leveraging the regenerative properties of SIS® technology, which potentially accelerates tissue regeneration. Established in 2002 and headquartered in the United States, the company received a noteworthy $3.50M Venture Round investment on November 8, 2017, signifying external validation and potential for continued growth and innovation.
This investment is indicative of Morris Innovative's potential to address unmet needs in cardiovascular care and its capacity to introduce disruptive solutions in the biotechnology and health care industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.50M | - | 08 Nov 2017 | |
| Venture Round | $1.18M | - | 05 Oct 2009 |
We care about your data, and we'd love to use cookies make your experience better.